The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma: A Children’s Oncology Group (COG) study.
 
Meaghan Granger
Consulting or Advisory Role - United Therapeutics
 
Gregory A. Yanik
No Relationships to Disclose
 
Arlene Naranjo
No Relationships to Disclose
 
Jeannine S. McCune
No Relationships to Disclose
 
Steven G. DuBois
Honoraria - Loxo
Research Funding - Merck (Inst); Millennium (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Loxo
 
Rochelle Bagatell
No Relationships to Disclose
 
Brian D. Weiss
No Relationships to Disclose
 
Stephan A. Grupp
Consulting or Advisory Role - Janssen; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Novartis
 
Sheena Cretella Tenney
No Relationships to Disclose
 
Shahab Asgharzadeh
No Relationships to Disclose
 
Michael D. Hogarty
Research Funding - Cancer Prevention Pharmaceuticals
 
Joseph Ezra Panoff
No Relationships to Disclose
 
John Han-Chih Chang
No Relationships to Disclose
 
Julie M Gastier-Foster
No Relationships to Disclose
 
Denise Mills
No Relationships to Disclose
 
Julie R. Park
Travel, Accommodations, Expenses - Roche